Page last updated: 2024-09-04

bazedoxifene and Rhabdomyosarcoma

bazedoxifene has been researched along with Rhabdomyosarcoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bian, Y; Bid, HK; Chen, X; Li, C; Li, H; Lin, J; Wei, J; Wu, X; Xiao, H; Zhao, C1

Other Studies

1 other study(ies) available for bazedoxifene and Rhabdomyosarcoma

ArticleYear
Repositioning Bazedoxifene as a novel IL-6/GP130 signaling antagonist for human rhabdomyosarcoma therapy.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Animals; Cell Line, Tumor; Cytokine Receptor gp130; Drug Screening Assays, Antitumor; Human Umbilical Vein Endothelial Cells; Humans; Indoles; Interleukin-6; Mice; Mice, Nude; Reverse Transcriptase Polymerase Chain Reaction; Rhabdomyosarcoma; Signal Transduction; Xenograft Model Antitumor Assays

2017